$CURR CURE Pharmaceutical Expands to Europe, Signs

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
147
$CURR CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today by CURE Pharmaceutical (OTC: CURR), the company is updating this release to include forward looking statements.

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products. The agreement grants ReLeaf Europe exclusive access to CURE’s encapsulation technology for certain oral and topical cannabis products in the Netherlands, the world’s first medical cannabis market. ReLeaf Europe products will be the first to use the CUREinside™ quality mark to bolster consumer confidence.

According to market research, Europe is one of the world’s largest medical cannabis markets due to various governments’ approval for medicinal purposes.

“ReLeaf Europe is one of the few pharmacy providers of pharmaceutical-grade medicinal cannabis oils in Europe and an ideal partner for our first step into the European market because of its commitment to establishing clinical evidence and following EU GMP and GDP standards,” said Jessica Rousset, COO of CURE. “Through this agreement, we will roll out our powered by CURE strategy that includes exclusive licensing relationships to build global market share.”

ReLeaf Europe is tackling the largest market in the world for cannabis by establishing a foothold in Holland – a market estimated to reach $2.6B by 2028 – and by pursuing innovative delivery systems and distribution networks.

“We are standard-bearers in clinical cannabis care in Europe and CURE shares our values in its science and manufacturing practices in seeking the highest of quality standards,” said Jesse Kuijper, CEO of ReLeaf Europe. “This collaboration will help accelerate our market presence through highly differentiated products.”

CURE will power several ReLeaf Europe products, including one sublingual tincture and two topical creams to be launched in 2020.

About CURE Pharmaceutical
CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an FDA- and DEA- registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform. CUREform™ includes CUREfilm®, one of the most advanced oral thin films on the market today; microCURE™, an innovative emulsion technology utilizing proprietary encapsulation techniques; and CUREpods™ a novel chewable delivery system. CUREform's combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.

For more information about CURE Pharmaceutical, please visit its website at www.curepharma.com.

About ReLeaf Europe

ReLeaf Europe bv is active since 2017 in the European pharmaceutical market. All products are distributed through licensed pharmacies, OTC as well as prescripted. Clinical Cannabis Care bv is a compounding pharmacy based in the Netherlands producing cannabis products for delivery direct to patients or through pharmacies. Cannadis Europe bv is developing EU-GMP THC and CBD API’s (Active Pharmaceutical Ingredients) for pharmacists in Europe as well API’s for scientific research studies to be launched in 2020. Both Clinical Cannabis Care bv and Cannadis Europe bv are part of ReLeaf Europe bv.

This press release contains forward-looking statements that involve risks and uncertainties. There are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the ability to successfully market the partnered products, the difficulty in predicting the timing or outcome of related research and development efforts, partnered product characteristics and indications, marketing approvals and launches of other products, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties and the ability to obtain financing on favorable terms. The forward-looking statements in this press release reflect the Company's judgment as of the date of this press release. The Company disclaims any intent or obligation to update these forward-looking statements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Media Contact:
Paulo Acuna
pacuna@olmsteadwilliams.com
310-824-9000
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saga Metals Advances Radar Project with HQ Drill Success

Updated Category News Views 141

Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...

Continue Reading
Vehicle Reliability Hinges on Design and Maintenance

Updated Category News Views 30

Why Some Cars Age Like Fine Wine—and Some Don't Here’s the thing—cars aren’t all made equal, and anybody who's tinkered around under the hood for a few years long knows that some vehicles just can’t hold it together as time marches on. Now, this ain't rocket science, but the truth is wrapped up in the complexity of designs and those pesky little maintenance...

Continue Reading
TagniFi Spread: AI Transforming Financial Analysis

Updated Category News Views 40

Ah, finance folks, we've all been there—lost in the trenches, teeth gritted as we manually grind through private company financials. It's like trying to piece together a 1,000-piece jigsaw puzzle without a picture of the final scene. But now, someone's come along and flipped on the light switch. Enter TagniFi Spread, the new AI-powered tool that's snapped a whole lot of...

Continue Reading
AI Governance Market to Hit $12.5B by 2030

Updated Category News Views 99

AI Governance: The Enforcer's Playground Well, with every Tom, Dick, and Harry out there tinkering with artificial intelligence, it's no shocker we've come to this. Peeled back, the AI governance platforms market's pegged to hit a whopping $12.5 billion by 2030. The AIMG's report spells this out with the kind of clarity even an intern could appreciate. But here's the rub:...

Continue Reading
TSX Surges Amid Earnings Wave and Market Momentum

Updated Category News Views 46

TSX Soars, But What's Driving the Surge? Gotta say, when the TSX leaps over 2% in a single day, it sets the stage for two things: excitement and scrutiny. On a balmy Wednesday, Canada's stock market stood tall at 36,317.67, up 785.39 points. Wall Street joined the dance too, with the Dow kicking up by 1,543.75 points. Good vibes all around — but hang on a minute. You...

Continue Reading
DraftKings Faces Scrutiny Over AI Use in Promotions

Updated Category News Views 61

DraftKings Under the Legal Microscope So here's a doozy that’s rattling through Beantown: DraftKings, the sportsbook titan, might be walking on financial eggshells thanks to their bold use of artificial intelligence. Shapiro Haber & Urmy, a doughty Boston legal jockey, is giving the high sign to users about a consumer class action investigation involving DraftKings'...

Continue Reading
Pearson-Westermann Partnership Boosts English Skills in Germany

Updated Category News Views 107

Revolutionizing English Education in Germany Alright, folks, here's the scoop for all you with a toe in education and workforce development. Pearson and Westermann are shaking hands to tackle one of the biggest skills needed in Germany: English proficiency. This might sound like a dry move on the surface, but trust me, it's a game-changer for students and job seekers...

Continue Reading
Cincoro Tequila Unveils Rare Añejo for Holidays

Updated Category News Views 92

Firing Up the Holiday Spirit with Cincoro Well, isn't this a timely toast to class? As if the tequila scene wasn't already brimming with options, Cincoro's decided to paint the town gold with a rare addition to its lineup. For those of you who treat your liquor collection like a stockpile of fine art, here's something that'll turn heads this holiday season—the Añejo...

Continue Reading
Texans Credit Union Ranks High in Workplace Satisfaction

Updated Category News Views 49

Building a Culture of Value and Growth Try saying no to recognition when you prioritize your people, and Texans Credit Union knows it well. Their consistent Top Workplace ranking—four years running, mind you—speaks volumes about a company truly valuing its workforce. Landing at No. 6 among midsize companies in The Dallas Morning News' 2026 D-FW list, they’re...

Continue Reading
Everest Group Faces Shaky Ground in Securities Fraud Suit

Updated Category News Views 128

Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Your Potential Gains with W.W. Grainger's Growth

Updated Category News Views 200

W.W. Grainger: A Decade of Impressive Growth W.W. Grainger (NYSE: GWW) has consistently outperformed the market over the last ten years, showcasing a remarkable annualized growth rate of 4.85%. This translates to an average annual return of 16.04%. Investors who recognized this potential have seen substantial financial growth, particularly those who made early...

Continue Reading
Cipher Mining Celebrates Strategic Acquisition Boosting Growth

Updated Category News Views 84

Cipher Mining Inc. Expands Operations with Major Acquisition Cipher Mining Inc. (NASDAQ: CIFR) has recently witnessed a surge in its stock price, fueled by favorable reactions from investors to its latest strategic decision. The company has announced the successful acquisition of a significant data center site, strengthening its foothold in the cryptocurrency mining...

Continue Reading
Schwarzwald Capital's Investment to Transform Digital Payments

Updated Category News Views 226

Schwarzwald Capital's Strategic Moves in Digital Payment Security Schwarzwald Capital, a distinguished venture capital firm dedicated to advancing fintech and the creator economy, has announced a pivotal investment in Vesta. This collaboration aims to enhance fraud prevention measures in digital transactions, emphasizing the vital need for secure and seamless online...

Continue Reading
Understanding Floating Rate Loans Refinancing Strategies

Updated Category News Views 134

Refinancing Floating Rate Loans: Insights from Nykredit Group Nykredit Group has taken a significant step by completing the auctions necessary for refinancing floating rate loans. This operation is essential for managing interest rate risks and enhancing loan structures for better capital efficiency. Details of the Refinancing Process The refinancing process is scheduled...

Continue Reading
TransDigm Group Achieves Impressive Q3 Growth Metrics

Updated Category News Views 147

TransDigm Group Reports Significant Q3 Growth TransDigm Group Incorporated (NYSE: TDG), a prominent designer and producer of highly engineered aircraft components, recently announced its impressive financial results for the third quarter concluding June 28, 2025. Key Financial Highlights of the Quarter The company demonstrated remarkable performance during the third...

Continue Reading